CJC-1295
LIMITED EVIDENCEAlso known as: GHRH analogue
Investigational
Educational Overview
A growth-hormone-releasing hormone analogue studied for its effect on GH and IGF-1.
Research Mechanism
Stimulates GH secretion in small studies; long-term outcomes and safety in healthy adults are unknown.
Areas of Study
- GH/IGF-1 response (small human studies)
Safety Considerations
Long-term safety unknown. Often discussed alongside ipamorelin.
Frequently Asked Questions
Does it raise GH?
Small studies show GH/IGF-1 increases; outcome data is limited.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-06-01 · Status: draft · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.